Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 16304412)

1.

Platelets and thrombosis in myeloproliferative diseases.

Harrison CN.

Hematology Am Soc Hematol Educ Program. 2005:409-15.

3.

Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.

Wehmeier A, Südhoff T, Meierkord F.

Semin Thromb Hemost. 1997;23(4):391-402. Review.

PMID:
9263357
4.

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.

Villmow T, Kemkes-Matthes B, Matzdorff AC.

Thromb Res. 2002 Nov 1;108(2-3):139-45.

PMID:
12590950
5.

Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia.

Vannucchi AM.

Intern Emerg Med. 2010 Jun;5(3):177-84. doi: 10.1007/s11739-009-0319-3. Epub 2009 Sep 30. Review.

PMID:
19789961
6.

Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.

Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.

Semin Thromb Hemost. 2006 Apr;32(3):174-207. Review.

PMID:
16673274
7.
8.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Hsieh PP, Olsen RJ, O'Malley DP, Konoplev SN, Hussong JW, Dunphy CH, Perkins SL, Cheng L, Lin P, Chang CC.

Mod Pathol. 2007 Sep;20(9):929-35. Epub 2007 Jul 20.

9.

Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.

Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraro N.

Eur J Cancer Clin Oncol. 1983 Nov;19(11):1593-9.

PMID:
6580171
10.
11.

JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera.

Zhang S, Qiu H, Fischer BS, Li W, Duan L, Sun X, Xu W, Li J.

Leuk Lymphoma. 2008 Apr;49(4):696-9. doi: 10.1080/10428190701885537.

PMID:
18398736
12.

Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders.

Marchetti M, Falanga A.

Pathophysiol Haemost Thromb. 2008;36(3-4):148-59. doi: 10.1159/000175153. Epub 2009 Jan 27. Review.

PMID:
19176988
13.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.

Orv Hetil. 2006 Nov 12;147(45):2175-9. Hungarian.

PMID:
17402211
14.

Chronic myeloproliferative disorders.

Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M.

Hematology Am Soc Hematol Educ Program. 2003:200-24. Review.

15.

Management of polycythemia vera and essential thrombocythemia.

Campbell PJ, Green AR.

Hematology Am Soc Hematol Educ Program. 2005:201-8.

16.

Defining the thrombotic risk in patients with myeloproliferative neoplasms.

Vianello F, Battisti A, Cella G, Marchetti M, Falanga A.

ScientificWorldJournal. 2011 May 26;11:1131-7. doi: 10.1100/tsw.2011.108. Review.

17.

Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera.

Randi ML, Brunati AM, Scapin M, Frasson M, Deana R, Magrin E, Fabris F, Donella-Deana A.

Blood. 2010 Jan 21;115(3):667-76. doi: 10.1182/blood-2008-12-196535. Epub 2009 Nov 12.

18.

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.

Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foà R, Larocca LM.

J Clin Oncol. 2007 Mar 20;25(9):1048-53.

19.

A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.

Wehmeier A, Fricke S, Scharf RE, Schneider W.

Eur J Haematol. 1990 Oct;45(4):191-7.

PMID:
2146144
20.

Clinical applications of molecular haematology: JAK2 in myeloproliferative disorders.

Agarwal MB.

J Assoc Physicians India. 2007 Jul;55:507-10. Review.

PMID:
17907502
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk